MoneyBloomberg Markets
Novartis Inks Chinese mRNA-Therapy Deal for Up to $7.8 Billion
Novartis AG will license a messenger RNA-based autoimmune therapy from China’s Abogen Biosciences, in a deal worth as much as $7.8 billion.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
Novartis AG will license a messenger RNA-based autoimmune therapy from China’s Abogen Biosciences, in a deal worth as much as $7.8 billion.
Join the argument
House rules →Comments load as you scroll.